Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?

Authors	Mariangela Allocca, Gionata Fiorino, Silvio Danese
Journal	Digestive diseases and sciences (Dig Dis Sci) Vol. 62 Issue 11 Pg. 2964-2965 (11 2017) ISSN: 1573-2568 [Electronic] United States
PMID	28776140 (Publication Type: Editorial, Comment)
Chemical References	Antibodies, Monoclonal Biosimilar Pharmaceuticals Infliximab
Topics	Antibodies, Monoclonal Biosimilar Pharmaceuticals Humans Inflammatory Bowel Diseases Infliximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!